Intrinsic value of Proto Labs - PRLB

Previous Close

$161.50

  Intrinsic Value

$2.90

stock screener

  Rating & Target

str. sell

-98%

Previous close

$161.50

 
Intrinsic value

$2.90

 
Up/down potential

-98%

 
Rating

str. sell

We calculate the intrinsic value of PRLB stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 4.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  33.70
  30.83
  28.25
  25.92
  23.83
  21.95
  20.25
  18.73
  17.35
  16.12
  15.01
  14.01
  13.11
  12.30
  11.57
  10.91
  10.32
  9.79
  9.31
  8.88
  8.49
  8.14
  7.83
  7.54
  7.29
  7.06
  6.85
  6.67
  6.50
  6.35
Revenue, $m
  461
  603
  773
  973
  1,205
  1,469
  1,767
  2,098
  2,462
  2,859
  3,288
  3,749
  4,240
  4,761
  5,312
  5,891
  6,499
  7,135
  7,799
  8,492
  9,212
  9,962
  10,742
  11,552
  12,394
  13,270
  14,179
  15,125
  16,108
  17,131
Variable operating expenses, $m
  355
  460
  586
  734
  905
  1,101
  1,321
  1,566
  1,835
  2,128
  2,430
  2,771
  3,134
  3,519
  3,926
  4,355
  4,804
  5,274
  5,765
  6,277
  6,809
  7,364
  7,940
  8,539
  9,161
  9,808
  10,481
  11,180
  11,906
  12,663
Fixed operating expenses, $m
  3
  3
  3
  3
  3
  3
  3
  4
  4
  4
  4
  4
  4
  4
  4
  4
  4
  4
  5
  5
  5
  5
  5
  5
  5
  5
  5
  6
  6
  6
Total operating expenses, $m
  358
  463
  589
  737
  908
  1,104
  1,324
  1,570
  1,839
  2,132
  2,434
  2,775
  3,138
  3,523
  3,930
  4,359
  4,808
  5,278
  5,770
  6,282
  6,814
  7,369
  7,945
  8,544
  9,166
  9,813
  10,486
  11,186
  11,912
  12,669
Operating income, $m
  102
  139
  184
  236
  296
  365
  443
  529
  624
  727
  854
  974
  1,102
  1,238
  1,381
  1,532
  1,691
  1,857
  2,030
  2,210
  2,398
  2,594
  2,797
  3,008
  3,228
  3,456
  3,693
  3,940
  4,196
  4,463
EBITDA, $m
  137
  180
  232
  293
  364
  444
  535
  636
  747
  867
  998
  1,138
  1,288
  1,447
  1,615
  1,791
  1,976
  2,170
  2,372
  2,583
  2,803
  3,031
  3,269
  3,515
  3,772
  4,038
  4,315
  4,604
  4,903
  5,215
Interest expense (income), $m
  0
  0
  1
  2
  4
  5
  7
  10
  12
  15
  18
  21
  24
  28
  32
  37
  41
  46
  51
  56
  62
  67
  73
  79
  86
  92
  99
  107
  114
  122
  130
Earnings before tax, $m
  102
  138
  181
  232
  291
  358
  433
  517
  609
  710
  833
  949
  1,074
  1,206
  1,345
  1,491
  1,645
  1,806
  1,974
  2,149
  2,331
  2,521
  2,718
  2,923
  3,135
  3,357
  3,587
  3,826
  4,074
  4,333
Tax expense, $m
  28
  37
  49
  63
  79
  97
  117
  140
  164
  192
  225
  256
  290
  325
  363
  403
  444
  488
  533
  580
  629
  681
  734
  789
  847
  906
  968
  1,033
  1,100
  1,170
Net income, $m
  74
  101
  132
  169
  212
  261
  316
  377
  445
  518
  608
  693
  784
  880
  982
  1,089
  1,201
  1,318
  1,441
  1,569
  1,702
  1,840
  1,984
  2,133
  2,289
  2,450
  2,618
  2,793
  2,974
  3,163

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  621
  812
  1,041
  1,311
  1,624
  1,980
  2,382
  2,827
  3,318
  3,853
  4,431
  5,052
  5,714
  6,417
  7,159
  7,940
  8,759
  9,616
  10,511
  11,444
  12,416
  13,426
  14,477
  15,569
  16,704
  17,884
  19,109
  20,384
  21,709
  23,088
Adjusted assets (=assets-cash), $m
  621
  812
  1,041
  1,311
  1,624
  1,980
  2,382
  2,827
  3,318
  3,853
  4,431
  5,052
  5,714
  6,417
  7,159
  7,940
  8,759
  9,616
  10,511
  11,444
  12,416
  13,426
  14,477
  15,569
  16,704
  17,884
  19,109
  20,384
  21,709
  23,088
Revenue / Adjusted assets
  0.742
  0.743
  0.743
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
  0.742
Average production assets, $m
  265
  346
  444
  560
  693
  845
  1,016
  1,206
  1,416
  1,644
  1,891
  2,155
  2,438
  2,738
  3,054
  3,387
  3,737
  4,103
  4,485
  4,883
  5,297
  5,728
  6,177
  6,643
  7,127
  7,630
  8,153
  8,697
  9,262
  9,850
Working capital, $m
  43
  56
  72
  90
  112
  137
  164
  195
  229
  266
  306
  349
  394
  443
  494
  548
  604
  664
  725
  790
  857
  926
  999
  1,074
  1,153
  1,234
  1,319
  1,407
  1,498
  1,593
Total debt, $m
  23
  44
  70
  101
  136
  176
  222
  272
  327
  388
  453
  523
  598
  678
  761
  850
  942
  1,039
  1,140
  1,246
  1,355
  1,470
  1,588
  1,712
  1,840
  1,973
  2,112
  2,256
  2,406
  2,561
Total liabilities, $m
  70
  92
  118
  148
  184
  224
  269
  320
  375
  435
  501
  571
  646
  725
  809
  897
  990
  1,087
  1,188
  1,293
  1,403
  1,517
  1,636
  1,759
  1,888
  2,021
  2,159
  2,303
  2,453
  2,609
Total equity, $m
  551
  720
  924
  1,163
  1,440
  1,757
  2,112
  2,508
  2,943
  3,418
  3,931
  4,481
  5,068
  5,692
  6,350
  7,042
  7,769
  8,529
  9,323
  10,151
  11,013
  11,909
  12,841
  13,810
  14,817
  15,863
  16,950
  18,080
  19,256
  20,479
Total liabilities and equity, $m
  621
  812
  1,042
  1,311
  1,624
  1,981
  2,381
  2,828
  3,318
  3,853
  4,432
  5,052
  5,714
  6,417
  7,159
  7,939
  8,759
  9,616
  10,511
  11,444
  12,416
  13,426
  14,477
  15,569
  16,705
  17,884
  19,109
  20,383
  21,709
  23,088
Debt-to-equity ratio
  0.040
  0.060
  0.080
  0.090
  0.090
  0.100
  0.100
  0.110
  0.110
  0.110
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.120
  0.130
Adjusted equity ratio
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887
  0.887

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  74
  101
  132
  169
  212
  261
  316
  377
  445
  518
  608
  693
  784
  880
  982
  1,089
  1,201
  1,318
  1,441
  1,569
  1,702
  1,840
  1,984
  2,133
  2,289
  2,450
  2,618
  2,793
  2,974
  3,163
Depreciation, amort., depletion, $m
  35
  41
  49
  57
  68
  79
  92
  107
  123
  140
  144
  165
  186
  209
  233
  259
  285
  313
  342
  373
  404
  437
  472
  507
  544
  582
  622
  664
  707
  752
Funds from operations, $m
  109
  142
  181
  227
  280
  340
  409
  484
  567
  658
  752
  858
  970
  1,089
  1,215
  1,347
  1,486
  1,631
  1,783
  1,941
  2,106
  2,277
  2,455
  2,641
  2,833
  3,033
  3,241
  3,457
  3,681
  3,915
Change in working capital, $m
  11
  13
  16
  19
  22
  25
  28
  31
  34
  37
  40
  43
  46
  48
  51
  54
  57
  59
  62
  64
  67
  70
  73
  75
  78
  81
  85
  88
  91
  95
Cash from operations, $m
  99
  129
  165
  208
  258
  316
  381
  453
  534
  621
  712
  815
  924
  1,041
  1,164
  1,293
  1,430
  1,572
  1,721
  1,877
  2,039
  2,208
  2,383
  2,565
  2,755
  2,951
  3,156
  3,369
  3,590
  3,820
Maintenance CAPEX, $m
  -15
  -20
  -26
  -34
  -43
  -53
  -64
  -78
  -92
  -108
  -125
  -144
  -165
  -186
  -209
  -233
  -259
  -285
  -313
  -342
  -373
  -404
  -437
  -472
  -507
  -544
  -582
  -622
  -664
  -707
New CAPEX, $m
  -67
  -82
  -98
  -115
  -133
  -152
  -171
  -190
  -209
  -228
  -247
  -265
  -282
  -300
  -317
  -333
  -350
  -366
  -382
  -398
  -415
  -431
  -448
  -466
  -484
  -503
  -523
  -544
  -565
  -588
Cash from investing activities, $m
  -82
  -102
  -124
  -149
  -176
  -205
  -235
  -268
  -301
  -336
  -372
  -409
  -447
  -486
  -526
  -566
  -609
  -651
  -695
  -740
  -788
  -835
  -885
  -938
  -991
  -1,047
  -1,105
  -1,166
  -1,229
  -1,295
Free cash flow, $m
  16
  27
  41
  59
  82
  111
  145
  186
  232
  285
  340
  406
  477
  555
  638
  727
  821
  921
  1,026
  1,136
  1,252
  1,372
  1,497
  1,628
  1,763
  1,904
  2,051
  2,203
  2,360
  2,524
Issuance/(repayment) of debt, $m
  18
  22
  26
  31
  35
  40
  45
  50
  55
  60
  65
  70
  75
  79
  84
  88
  93
  97
  101
  105
  110
  114
  119
  123
  128
  133
  139
  144
  150
  156
Issuance/(repurchase) of shares, $m
  65
  69
  71
  70
  65
  55
  40
  18
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  83
  91
  97
  101
  100
  95
  85
  68
  55
  60
  65
  70
  75
  79
  84
  88
  93
  97
  101
  105
  110
  114
  119
  123
  128
  133
  139
  144
  150
  156
Total cash flow (excl. dividends), $m
  100
  118
  138
  160
  183
  206
  230
  254
  288
  345
  406
  476
  552
  634
  722
  815
  914
  1,018
  1,127
  1,242
  1,362
  1,486
  1,616
  1,751
  1,892
  2,037
  2,189
  2,347
  2,510
  2,680
Retained Cash Flow (-), $m
  -140
  -170
  -203
  -239
  -277
  -316
  -356
  -396
  -435
  -474
  -513
  -551
  -587
  -623
  -658
  -693
  -727
  -760
  -794
  -828
  -862
  -896
  -932
  -969
  -1,007
  -1,046
  -1,087
  -1,130
  -1,176
  -1,223
Prev. year cash balance distribution, $m
  50
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  10
  -52
  -66
  -80
  -95
  -110
  -126
  -141
  -148
  -129
  -107
  -75
  -35
  11
  64
  123
  187
  258
  334
  414
  500
  590
  684
  782
  885
  991
  1,102
  1,216
  1,335
  1,457
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  10
  -48
  -57
  -66
  -73
  -80
  -85
  -88
  -85
  -68
  -51
  -32
  -13
  4
  19
  31
  41
  47
  51
  53
  52
  49
  45
  40
  34
  29
  24
  19
  15
  11
Current shareholders' claim on cash, %
  98.3
  97.1
  96.1
  95.3
  94.7
  94.4
  94.1
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0
  94.0

Proto Labs, Inc. is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company's geographic segments include the United States, Europe and Japan. The Company targets its products to the product developers and engineers who use 3D computer-aided design (3D CAD) software to design products across a range of end markets. Its product lines include Injection Molding, CNC Machining and 3D Printing. Its Injection Molding product line is used for prototype, on-demand and short-run production. Its CNC Machining product line uses commercially available CNC machines to cut plastic or metal blocks into one or more custom parts. Its 3D Printing product line includes stereolithography (SL), selective laser sintering (SLS) and direct metal laser sintering (DMLS) processes. The Company also provides low-volume sheet metal fabrication services.

FINANCIAL RATIOS  of  Proto Labs (PRLB)

Valuation Ratios
P/E Ratio 99.5
Price to Sales 14.4
Price to Book 11.3
Price to Tangible Book
Price to Cash Flow 57.1
Price to Free Cash Flow 104.4
Growth Rates
Sales Growth Rate 12.9%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -22.7%
Cap. Spend. - 3 Yr. Gr. Rate 12.3%
Financial Strength
Quick Ratio NaN
Current Ratio 0.3
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 11.1%
Ret/ On Assets - 3 Yr. Avg. 14%
Return On Total Capital 12.1%
Ret/ On T. Cap. - 3 Yr. Avg. 15.2%
Return On Equity 12.1%
Return On Equity - 3 Yr. Avg. 15.2%
Asset Turnover 0.8
Profitability Ratios
Gross Margin 56%
Gross Margin - 3 Yr. Avg. 58.4%
EBITDA Margin 27.2%
EBITDA Margin - 3 Yr. Avg. 30.8%
Operating Margin 20.8%
Oper. Margin - 3 Yr. Avg. 25.1%
Pre-Tax Margin 21.5%
Pre-Tax Margin - 3 Yr. Avg. 25.4%
Net Profit Margin 14.4%
Net Profit Margin - 3 Yr. Avg. 17.4%
Effective Tax Rate 32.8%
Eff/ Tax Rate - 3 Yr. Avg. 31.6%
Payout Ratio 0%

PRLB stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the PRLB stock intrinsic value calculation we used $344.49 million for the last fiscal year's total revenue generated by Proto Labs. The default revenue input number comes from 0001 income statement of Proto Labs. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our PRLB stock valuation model: a) initial revenue growth rate of 33.7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for PRLB is calculated based on our internal credit rating of Proto Labs, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Proto Labs.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of PRLB stock the variable cost ratio is equal to 78.2%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $3 million in the base year in the intrinsic value calculation for PRLB stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Proto Labs.

Corporate tax rate of 27% is the nominal tax rate for Proto Labs. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the PRLB stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for PRLB are equal to 57.5%.

Life of production assets of 13.1 years is the average useful life of capital assets used in Proto Labs operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for PRLB is equal to 9.3%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $461.215 million for Proto Labs - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 27.027 million for Proto Labs is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Proto Labs at the current share price and the inputted number of shares is $4.4 billion.

RELATED COMPANIES Price Int.Val. Rating
DDD 3D Systems 18.85 0.63  str.sell
XONE ExOne 9.53 1.16  str.sell
ARCW ARC Group Worl 1.95 0.55  str.sell
VJET voxeljet ADR 4.02 1.14  str.sell
AIN Albany Interna 78.20 26.06  str.sell

COMPANY NEWS

▶ Did Proto Labs Inc (NYSE:PRLB) Create Value For Shareholders?   [Aug-24-18 02:21PM  Simply Wall St.]
▶ CloudSense Announces Impressive Board   [Aug-02-18 09:00AM  PR Newswire]
▶ Proto Labs: 2Q Earnings Snapshot   [06:11AM  Associated Press]
▶ 5 Hated Growth Stocks That You Shouldnt Ignore   [Jul-20-18 02:04PM  InvestorPlace]
▶ These 3 Stocks Doubled in 2017. Are They Still Buys?   [May-11-18 05:33PM  Motley Fool]
▶ Proto Labs, Inc. to Host Earnings Call   [Apr-26-18 06:55AM  ACCESSWIRE]
▶ Proto Labs: 1Q Earnings Snapshot   [06:11AM  Associated Press]
▶ 3 Stocks That Feel Like Netflix in 2002   [Apr-25-18 06:00AM  Motley Fool]
▶ 3 Top Growth Stocks to Buy in April   [Apr-11-18 09:15AM  Motley Fool]
▶ Is It Too Late To Buy Proto Labs Inc (NYSE:PRLB)?   [Mar-20-18 05:42PM  Simply Wall St.]
▶ Top Ranked Growth Stocks to Buy for March 15th   [Mar-15-18 08:31AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for March 14th   [Mar-14-18 08:49AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for March 12th   [Mar-12-18 07:56AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for March 1st   [Mar-01-18 08:48AM  Zacks]
▶ 13 Small-Cap Stocks With Wide Quantitative Moats   [Feb-20-18 06:00AM  Morningstar]
▶ Proto Labs Wraps Up 2017 on a Strong Note   [Feb-09-18 05:06PM  Motley Fool]
▶ Proto Labs beats 4Q profit forecasts   [06:19AM  Associated Press]
▶ Proto Labs, Inc. to Host Earnings Call   [06:10AM  ACCESSWIRE]
▶ Proto Labs Announces Analyst Day   [Nov-21-17 09:32AM  Business Wire]
▶ Proto Labs Manufactures Another Good Quarter; Stock Pops   [Oct-27-17 09:32AM  Motley Fool]
▶ Proto Labs, Inc. to Host Earnings Call   [Oct-26-17 06:40AM  ACCESSWIRE]
▶ Proto Labs tops Street 3Q forecasts   [06:35AM  Associated Press]
▶ ETFs with exposure to Proto Labs, Inc. : October 23, 2017   [Oct-23-17 10:59AM  Capital Cube]
▶ 3 Stocks That Look Just Like Starbucks in 1992   [Oct-12-17 06:13AM  Motley Fool]
▶ Is Stratasys Ltd. a Buy?   [Oct-04-17 07:40AM  Motley Fool]
▶ ETFs with exposure to Proto Labs, Inc. : October 2, 2017   [Oct-02-17 11:02AM  Capital Cube]
▶ Sisyphus Kinetic Art Tables Continue to Draw Demand   [Aug-29-17 10:00AM  Business Wire]
▶ Proto Labs beats 2Q profit forecasts   [Jul-27-17 03:44PM  Associated Press]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.